NCT04410848

Brief Summary

Choledocholithiasis refers to the presence of gallstones within the common bile duct. It is proposed to look for markers that help in the diagnosis and in differentiating between retained and migrated gallstones. The selection of patients is a very important aspect, due to the economic aspects and possible complications. Taking advantage of the development of technology, the improvement in computer systems, the use of artificial intelligence and a symbolic regression model that works to predict the presence of choledocholithiasis and provide evidence that clarifies the treatment of patients with this pathology, especially in this group where there is a bigger controversy.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
200

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jun 2019

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 7, 2019

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

January 20, 2020

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2020

Completed
2 days until next milestone

First Posted

Study publicly available on registry

June 1, 2020

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2020

Completed
Last Updated

June 1, 2020

Status Verified

May 1, 2020

Enrollment Period

12 months

First QC Date

January 20, 2020

Last Update Submit

May 29, 2020

Conditions

Outcome Measures

Primary Outcomes (1)

  • To validate prospectively a symbolic regression model to predict choledocholithiasis

    To validate a model to predict choledocholithiasis compared clinical predictors.

    72 horas

Study Arms (1)

All patient with suspicion of choledocholithiasis

Patient with the suspect of common biliary duct stone for pain type colic in the right upper quadrant abdomen, the elevation of bilirubin, alkaline phosphatase, pancreatitis, dilated common bile duct and cholangitis. According to the criteria to assign the risk of choledocholithiasis. We are going to validate a scale based on intelligence artificial compared to the clinical predictor.

Other: To determine the diagnostic of Choledocholithiasis with symbolic regression model

Interventions

To determine the diagnostic of Choledocholithiasis with symbolic regression model

All patient with suspicion of choledocholithiasis

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients with clinical suspicion of choledocholithiasis.

You may qualify if:

  • Patients above 18 with clinical suspicion of choledocholithiasis by biliary-type pain, laboratory testing that reveals a cholestatic pattern of liver test abnormalities, biliary pancreatitis or dilated common bile duct

You may not qualify if:

  • Patient with a history of cholecystectomy
  • History of previous ERCP or surgery involving bile duct
  • Patient who could not be followed
  • Patient with other pathology that causes alteration of liver function test.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hospital Universitario Dr. Jose E. Gonzalez, Universidad Autónoma de Nuevo León

Monterrey, Nuevo León, 64460, Mexico

RECRUITING

MeSH Terms

Conditions

Gallstones

Condition Hierarchy (Ancestors)

CholelithiasisBiliary Tract DiseasesDigestive System DiseasesCholecystolithiasisGallbladder DiseasesCalculiPathological Conditions, AnatomicalPathological Conditions, Signs and Symptoms

Study Officials

  • José A. González González, MD

    José Eleuterio González University Hospital

    STUDY DIRECTOR

Central Study Contacts

Carlos A. Herrera Figueroa, M.D

CONTACT

José A. González González, MD

CONTACT

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

January 20, 2020

First Posted

June 1, 2020

Study Start

June 7, 2019

Primary Completion

May 30, 2020

Study Completion

July 31, 2020

Last Updated

June 1, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations